Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (41-50 of 386) with videos related to

Pageof 39
Sort By:
British Journal of Nursing (Mark Allen Publishing)|June 29, 2018
Limitations of track and trigger systems and the National Early Warning Score. Part 2: sensitivity versus specificitySteven Grant, Kevin Crimmons
Autophagy|February 22, 2015
BCL2L11/Bim as a dual-agent regulating autophagy and apoptosis in drug resistanceYun Dai, Steven Grant
Expert Review of Hematology|November 14, 2012
Complementary combinations: what treatments will become key to the battle against acute myelogenous leukemia?Prithviraj Bose, Steven Grant
Current Opinion in Pharmacology|August 7, 2003
Cyclin-dependent kinase inhibitorsYun Dai, Steven Grant
Current Drug Targets|June 23, 2007
Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemiasSteven Grant, Paul Dent
Cancer Biology & Therapy|January 11, 2005
Irofulven: resurgence for alkylating therapy in cancer?Paul Dent, Steven Grant
Cancer Biology & Therapy|April 27, 2004
Activation of MAP kinase pathways by TRAIL: don't expect the obviousSteven Grant, Paul Dent
Cancer Research|April 6, 2007
Targeting multiple arms of the apoptotic regulatory machineryYun Dai, Steven Grant
Cell Cycle (Georgetown, Tex.)|November 14, 2002
UCN-01 (7-hydroxystauorsporine) blocks PMA-induced maturation and reciprocally promotes apoptosis in human myelomonocytic leukemia cells (U937)Mohamed Rahmani, Steven Grant
Leukemia Research Reports|August 27, 2013
Mcl-1 as a Therapeutic Target in Acute Myelogenous Leukemia (AML)Prithviraj Bose, Steven Grant
Pageof 39

Showing results (41-50 of 386) with videos related to

Sort By:
Pageof 39
British Journal of Nursing (Mark Allen Publishing)|June 29, 2018
Limitations of track and trigger systems and the National Early Warning Score. Part 2: sensitivity versus specificitySteven Grant, Kevin Crimmons
Autophagy|February 22, 2015
BCL2L11/Bim as a dual-agent regulating autophagy and apoptosis in drug resistanceYun Dai, Steven Grant
Expert Review of Hematology|November 14, 2012
Complementary combinations: what treatments will become key to the battle against acute myelogenous leukemia?Prithviraj Bose, Steven Grant
Current Opinion in Pharmacology|August 7, 2003
Cyclin-dependent kinase inhibitorsYun Dai, Steven Grant
Current Drug Targets|June 23, 2007
Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemiasSteven Grant, Paul Dent
Cancer Biology & Therapy|January 11, 2005
Irofulven: resurgence for alkylating therapy in cancer?Paul Dent, Steven Grant
Cancer Biology & Therapy|April 27, 2004
Activation of MAP kinase pathways by TRAIL: don't expect the obviousSteven Grant, Paul Dent
Cancer Research|April 6, 2007
Targeting multiple arms of the apoptotic regulatory machineryYun Dai, Steven Grant
Cell Cycle (Georgetown, Tex.)|November 14, 2002
UCN-01 (7-hydroxystauorsporine) blocks PMA-induced maturation and reciprocally promotes apoptosis in human myelomonocytic leukemia cells (U937)Mohamed Rahmani, Steven Grant
Leukemia Research Reports|August 27, 2013
Mcl-1 as a Therapeutic Target in Acute Myelogenous Leukemia (AML)Prithviraj Bose, Steven Grant
Pageof 39